BPC 157 There are currently no published randomized controlled trials (RCTs) of BPC 157 in humans. All existing evidence comes from preclinical animal studies, primarily in rodent models. The absence of rigorous human RCTs In this video, I discuss the dosage recommendations for BPC 157. Although there are no human clinical trials on optimal dosing, we rely on animal literature and anecdotal evidence. For oral BPC 157 in Australia: Benefits, side effects, risks and legality The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 & TB 500 Wolverine Stack in Southlake, TX